Cardiovascular Disease Study
Regain control of your cardiovascular health.
We’re actively recruiting for a medical study examining the safety and efficacy of an investigational medicinal product for people with cardiovascular disease.
Eligibility
- Aged 55 years or older
- History of cardiovascular disease
- BMI of 25 or more
Location
VIC, NSW, SA, WA, ACT, and TAS
Coeliac Study
Don’t let Coeliac disease control your life.
This study aims to evaluate the safety and effectiveness of an investigational medication in the treatment of Coeliac disease, an autoimmune condition that can cause gut issues, chronic fatigue, and other adverse reactions when gluten is ingested.
Eligibility
- 18 - 70 years
- Medically diagnosed with Coeliac disease
- Have been managing Coeliac disease symptoms with a gluten-free diet for at least 12 months
Location
VIC, NSW, and QLD
Dry Eye Disease Study
Help Investigate a Potential New treatment
This study aims to test the safety and efficacy of a new eye drop solution in people with Dry Eye Disease (DED). DED can cause discomfort and vision problems due to damage to collagen in the eye. This potential new treatment is designed to repair the damaged collagen and provide better relief from DED symptoms.
Eligibility
- 18+
- Have had DED for at least 6 months. Have used or wanted to use eye drops for at least 6 months.
Location
VIC, NSW, and QLD
Dry Eye and Autoimmune Condition Study
Help investigate a potential new treatment.
This study aims to test the safety and therapeutic effect of a potential new treatment (eye drop suspension) in people with autoimmune conditions who are suffering from dry eyes.
Eligibility
- 18 to 85 years
- Have had ongoing dry eyes for at least 6 months
- Have been using artificial tears (e.g. lubricating eye drops) at least twice daily for 30 days or more
- Have a history of systemic inflammatory autoimmune disease
Location
VIC, NSW, QLD, and WA
.png?width=80&height=80&name=Evrima%20-%20Website%20Trial%20Icon%20(ADHD).png)
Insomnia Study
Tired of sleepless nights?
This medical study aims to evaluate the efficacy and safety of CBD TPM (Cannabidiol, Tocopheryl Phosphate Mixture) capsules in adults to reduce the severity of insomnia symptoms.
Eligibility
- 18+
- Have difficulty getting to sleep, staying asleep and/or waking up earlier in the morning than desired
- OR have been diagnosed with insomnia.
Location
VIC, NSW, QLD, and WA
Liver Disease Study
Take back control of your liver health!
Help researchers evaluate the effectiveness of an investigational medication in the treatment of non-alcoholic steatohepatitis (NASH), an advanced form of non-alcoholic fatty liver disease (NAFLD).
Eligibility
- 18+
- Had a liver biopsy confirming NASH
- Moderate to significant liver fibrosis
Location
VIC, NSW, QLD, SA, and WA
MAC Lung Infection Study
Help Investigate a Potential New treatment
This study aims to evaluate the safety and effectiveness of a potential treatment option for patients with nontuberculous mycobacteria (NTM).
Eligibility
- 18+
- Newly diagnosed with Nontuberculous Mycobacterial (NTM) lung infection.
Location
VIC, QLD, and SA
NAFLD and Obesity Study
Help make medical breakthroughs happen in the treatment of NAFLD!
We’re currently recruiting for a new clinical trial that will be assessing the safety and effectiveness of the investigational medication in the treatment of NAFLD.
Eligibility
- Aged 18 to 70
- BMI ≥ 30kg/m2
Location
WA
Respiratory Studies
Do you suffer from wheezing, coughing, or shortness of breath?
Help researchers investigate potential new treatments for respiratory conditions.
Eligibility
- Asthma
- Chronic cough
- COPD
- IPF
Location
WA
Rheumatoid Arthritis Study
Help researchers investigate potential new treatments!
Help researchers investigate potential new treatments for Rheumatoid Arthritis
Eligibility
- 18+
- Located in Perth
Location
WA
ADHD Studies
Contribute to potentially ground-breaking research!
Help researchers to develop new treatments that could help people with ADHD manage their symptoms and improve their well-being.
Eligibility
- 18+
Location
Australia (all)
Shingles Study
Help Explore New Options for Symptom Relief
This study aims to evaluate the safety and tolerability of a topical product in reducing the pain associated with shingles. Shingles is a viral infection that commonly causes a painful, blistering rash on one side of the body, and it typically affects people aged 50 and older or those with weakened immune systems.
Eligibility
- Aged 18 or over Positive shingles diagnosis Symptoms must have started in the past FIVE days
Location
NSW and VIC